Guchang Zhixie Wan protects mice against dextran sulfate sodium-induced colitis through modulating the gut microbiota in colon. (5th October 2020)
- Record Type:
- Journal Article
- Title:
- Guchang Zhixie Wan protects mice against dextran sulfate sodium-induced colitis through modulating the gut microbiota in colon. (5th October 2020)
- Main Title:
- Guchang Zhixie Wan protects mice against dextran sulfate sodium-induced colitis through modulating the gut microbiota in colon
- Authors:
- Wang, Zheng
Liang, Yanni
Yu, Jingao
Zhang, Dongbo
Ren, Langlang
Zhang, Zhen
Liu, Yanru
Wu, Xue
Liu, Li
Tang, Zhishu - Abstract:
- Abstract: Ethnopharmacological relevance: Guchang Zhixie Wan (GC) is a traditional Chinese patent medicine used in the treatment of colitis in clinical trials. Though the notable effect of GC on colitis, the concrete mechanism of GC remain elusive. Emerging evidence showed that the imbalances of inflammatory cytokines and gut microbiota were both closely related to the initiation and progression of colitis. Aim of the study: To elucidate the relationship between the protective effects of GC on colitis and gut microbiota. Materials and methods: Male Kunming (KM) mice were enrolled in our work to establish colitis model induced by dextran sulfate sodium (DSS). The colitis mice were randomly divided into different groups and treated orally with 125 mg/kg of sulfasalazine (positive control) and 25, 50, 100 mg/kg of GC for 7 days, respectively. Inflammation cytokines of IL-1β, IL-4, IL-6, IL-8, IL-11, IL-12 and TNF-α were detected by ELISA analysis and the histological changes were detected by H&E staining. Gut microbiota diversity was analyzed by 16S rDNA sequencing. Metagenomes analysis were also conducted to reflect the protective effects of GC on colitis. Results: The results of CAS (Clinical Activity Score) confirmed the protective effects of GC on colitis. After administration of GC, the levels of pro-inflammatory cytokines IL-1β, IL-6, IL-8, IL-11, IL-12 and TNF-α were all decreased while the anti-inflammatory cytokines IL-4 was slightly increased, indicating that GC couldAbstract: Ethnopharmacological relevance: Guchang Zhixie Wan (GC) is a traditional Chinese patent medicine used in the treatment of colitis in clinical trials. Though the notable effect of GC on colitis, the concrete mechanism of GC remain elusive. Emerging evidence showed that the imbalances of inflammatory cytokines and gut microbiota were both closely related to the initiation and progression of colitis. Aim of the study: To elucidate the relationship between the protective effects of GC on colitis and gut microbiota. Materials and methods: Male Kunming (KM) mice were enrolled in our work to establish colitis model induced by dextran sulfate sodium (DSS). The colitis mice were randomly divided into different groups and treated orally with 125 mg/kg of sulfasalazine (positive control) and 25, 50, 100 mg/kg of GC for 7 days, respectively. Inflammation cytokines of IL-1β, IL-4, IL-6, IL-8, IL-11, IL-12 and TNF-α were detected by ELISA analysis and the histological changes were detected by H&E staining. Gut microbiota diversity was analyzed by 16S rDNA sequencing. Metagenomes analysis were also conducted to reflect the protective effects of GC on colitis. Results: The results of CAS (Clinical Activity Score) confirmed the protective effects of GC on colitis. After administration of GC, the levels of pro-inflammatory cytokines IL-1β, IL-6, IL-8, IL-11, IL-12 and TNF-α were all decreased while the anti-inflammatory cytokines IL-4 was slightly increased, indicating that GC could down regulate pro-inflammatory cytokines. H&E staining revealed that GC could improve the histopathological structure of the colon tissue. The results of 16S rDNA sequences analysis showed that GC could decrease the relative abundance of Turicibacter and increase the relative abundance of Ruminococcaceae_UCG-005 . Conclusion: GC greatly improve the health condition of colitis mice induced by DSS through improving the imbalances of inflammatory cytokines and gut microbiota. Graphical abstract: Image 1 … (more)
- Is Part Of:
- Journal of ethnopharmacology. Volume 260(2020)
- Journal:
- Journal of ethnopharmacology
- Issue:
- Volume 260(2020)
- Issue Display:
- Volume 260, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 260
- Issue:
- 2020
- Issue Sort Value:
- 2020-0260-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-10-05
- Subjects:
- Colitis -- GC -- DSS -- Inflammation -- Gut microbiota
Ethnopharmacology -- Periodicals
Pharmacognosy -- Periodicals
Herbs -- Periodicals
Herbs -- Periodicals
Pharmacognosy -- Periodicals
Pharmacognosie -- Périodiques
Herbes -- Périodiques
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03788741 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jep.2020.112991 ↗
- Languages:
- English
- ISSNs:
- 0378-8741
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.602400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22346.xml